MetaVia (MTVA) Times Interest Earned (2015 - 2025)
MetaVia's (MTVA) quarterly Times Interest Earned came in at -$0.11 in Q4 2025, up 68.16% YoY from -$0.07 in Q4 2024, and up 68.16% on a QoQ basis from -$0.35 in Q4 2024.
MetaVia (MTVA) Times Interest Earned (2015 - 2025) Analysis & Trends
MetaVia (MTVA) has 11 years of Times Interest Earned data on file, last reported at -$0.11 in Q4 2025.
- Quarterly Times Interest Earned rose 68.16% year-over-year to -$0.11 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.74 (up 58.65% YoY) and the FY2025 annual result came in at -$0.74, up 58.65% from the prior year.
- Times Interest Earned advanced to -$0.11 in Q4 2025, from -$0.35 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $341.67 in Q4 2023 to a low of -$2520.0 in Q1 2023.
- A 5-year average of -$358.99 and a median of -$287.42 in 2021 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 6972.64% in 2023, down 603.17% in 2023.
- Tracing MTVA's Times Interest Earned over 5 years: stood at -$571.25 in 2021, then surged by 99.13% to -$4.97 in 2022, then surged by 6972.64% to $341.67 in 2023, then plunged by 100.1% to -$0.35 in 2024, then surged by 68.16% to -$0.11 in 2025.
- The last three Times Interest Earned figures came in at -$0.11 (Q4 2025), -$0.35 (Q4 2024), and -$480.19 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | MetaVia | 8.72 Mn | -3.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.11 |
| Dec 31, 2024 | -0.35 |
| Jun 30, 2024 | -480.19 |
| Mar 31, 2024 | -327.67 |
| Dec 31, 2023 | 341.67 |
| Sep 30, 2023 | -99.47 |
| Mar 31, 2023 | -2,520.00 |
| Dec 31, 2022 | -4.97 |
| Sep 30, 2022 | -344.89 |
| Jun 30, 2022 | -38.32 |
| Mar 31, 2022 | -358.38 |
| Dec 31, 2021 | -571.25 |
| Sep 30, 2021 | -287.42 |
| Jun 30, 2021 | -279.07 |
| Mar 31, 2021 | -414.50 |
| Dec 31, 2020 | -2,437.75 |
| Sep 30, 2020 | -151.70 |
| Jun 30, 2020 | -102.65 |
| Mar 31, 2020 | -294.63 |
| Dec 31, 2019 | 741.33 |